1. Home
  2. TPH vs IOVA Comparison

TPH vs IOVA Comparison

Compare TPH & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPH
  • IOVA
  • Stock Information
  • Founded
  • TPH 2009
  • IOVA 2007
  • Country
  • TPH United States
  • IOVA United States
  • Employees
  • TPH N/A
  • IOVA N/A
  • Industry
  • TPH Homebuilding
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TPH Consumer Discretionary
  • IOVA Health Care
  • Exchange
  • TPH Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • TPH 2.8B
  • IOVA 771.4M
  • IPO Year
  • TPH N/A
  • IOVA N/A
  • Fundamental
  • Price
  • TPH $32.11
  • IOVA $1.71
  • Analyst Decision
  • TPH Strong Buy
  • IOVA Buy
  • Analyst Count
  • TPH 5
  • IOVA 10
  • Target Price
  • TPH $42.80
  • IOVA $12.22
  • AVG Volume (30 Days)
  • TPH 941.2K
  • IOVA 11.8M
  • Earning Date
  • TPH 07-24-2025
  • IOVA 08-07-2025
  • Dividend Yield
  • TPH N/A
  • IOVA N/A
  • EPS Growth
  • TPH 20.35
  • IOVA N/A
  • EPS
  • TPH 4.51
  • IOVA N/A
  • Revenue
  • TPH $4,294,395,999.00
  • IOVA $212,679,000.00
  • Revenue This Year
  • TPH N/A
  • IOVA $86.62
  • Revenue Next Year
  • TPH $7.76
  • IOVA $69.95
  • P/E Ratio
  • TPH $7.12
  • IOVA N/A
  • Revenue Growth
  • TPH 10.82
  • IOVA 11070.12
  • 52 Week Low
  • TPH $27.90
  • IOVA $1.64
  • 52 Week High
  • TPH $47.78
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • TPH 56.39
  • IOVA 36.89
  • Support Level
  • TPH $30.76
  • IOVA $1.95
  • Resistance Level
  • TPH $32.45
  • IOVA $2.47
  • Average True Range (ATR)
  • TPH 0.91
  • IOVA 0.16
  • MACD
  • TPH 0.16
  • IOVA -0.00
  • Stochastic Oscillator
  • TPH 75.00
  • IOVA 6.41

About TPH Tri Pointe Homes Inc.

Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company is engaged in the design, construction, and sale of single-family attached and detached homes in different states across the United States. Its operations are organized into two principal businesses: homebuilding. which generates key revenue, and financial services. The homebuilding business has three reportable operating segments, based on the geographical layout of the markets, and includes West region, Central region, and East region. The company's financial services operation is comprised of its Tri Pointe Connect mortgage financing operations, Tri Pointe Assurance title and escrow services operations, and Tri Pointe Advantage property and casualty insurance agency operations.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: